As for other conditions (e.g., allergic reactions) mechanisms driving the change in phenotype of allergen-specific CD4+ T cell effectors following immunotherapy remain to be determined (Holt and Thomas, 2005; van Oosterhout and Motta, 2005). Here, CD4 is linked to allergic disease.